000 | 03089nam a22003857a 4500 | ||
---|---|---|---|
008 | 210628s20212021 xxu||||| |||| 00| 0 eng d | ||
022 | _a2078-6891 | ||
024 | _a10.21037/jgo-21-133 [doi] | ||
024 | _ajgo-12-02-433 [pii] | ||
024 | _aPMC8107594 [pmc] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a34012637 | ||
245 | _aUtility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage. | ||
251 | _aJournal of Gastrointestinal Oncology. 12(2):433-445, 2021 Apr. | ||
252 | _aJ. gastrointest. oncol.. 12(2):433-445, 2021 Apr. | ||
253 | _aJournal of gastrointestinal oncology | ||
260 | _c2021 | ||
260 | _fFY2021 | ||
260 | _p2021 Apr | ||
265 | _sppublish | ||
266 | _d2021-06-28 | ||
520 | _aBackground: Feeding jejunostomy is widely used for enteral nutrition (EN) after esophagectomy; however, its risks and benefits are still controversial. We aimed to evaluate the short-term and long-term outcomes of feeding jejunal tube (FJT) in patients undergoing esophagectomy for esophageal squamous cell carcinoma (ESCC) who were deemed high-risk for anastomotic leakage. | ||
520 | _aConclusions: FJT showed acceptable safety profile along with potential benefits for ESCC patients with a high presumed risk of anastomotic leakage. While FJT does not impact OS, placement of FJT should be considered in esophagectomy patients and tailored to individual patients based on their leak-risk profile. Copyright 2021 Journal of Gastrointestinal Oncology. All rights reserved. | ||
520 | _aMethods: We retrospectively analyzed 716 patients who underwent esophagectomy with (FJT group, n=68) or without (control group, n=648) intraoperative placement of FJT. Propensity score matching (PSM) was used for the adjustment of confounding factors. Risk level for anastomotic leakage was determined for every patient after PSM. | ||
520 | _aResults: Patients in the FJT group were at higher risk of anastomotic leakage (14.9% vs. 11.3%), and had a statistically non-significant increase of postoperative complications [31.3% vs. 21.8%, odds ratio (OR) =1.139, 95% confidence interval (CI), 0.947-1.370, P=0.141] after PSM. Medical expenditure, length of postoperative hospital stay, and short-term mortality were similar between the FJT and control groups. Placement of FJT appeared to accelerate the recovery of anastomotic leakage (27.2 vs. 37.4 d, P=0.073). Patients in FJT group achieved comparable overall survival (OS) both before [hazard ratio (HR) =0.850, P=0.390] and after (HR =0.797, P=0.292) PSM. | ||
546 | _aEnglish | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aSurgery/Thoracic Surgery | ||
657 | _aJournal Article | ||
700 | _aGaur Khaitan, Puja | ||
790 | _aChen G, Deng C, Huang S, Khaitan PG, Koyanagi K, Liu H, Ozawa S, Piessen G, Qiao G, Shi R, Tian D, Wu H, Wu Y, Zhou Z, Zhuang W | ||
856 |
_uhttps://dx.doi.org/10.21037/jgo-21-133 _zhttps://dx.doi.org/10.21037/jgo-21-133 |
||
942 |
_cART _dArticle |
||
999 |
_c6548 _d6548 |